Zurich shareholders approve all Board proposals at Annual General Meeting
- Michel M. Liès confirmed as Chairman of the Board of Directors
- Peter Maurer elected as new member to join the Board on October 1, 2022; all other Board members standing for re-election confirmed
- Dividend of CHF 22 per share and all other Board proposals approved
The shareholders of Zurich Insurance Group Ltd (Zurich) confirmed Michel M. Liès as Chairman of the Board of Directors at today’s Annual General Meeting (AGM). They also elected all the other current Board members who stood for re-election, and elected Peter Maurer as a new member of the Board as of October 1, 2022.
Peter Maurer
As of October 1, 2022, the Board will have 12 members, with equal gender representation.
Due to COVID-19, the meeting took place without the physical presence of shareholders, who were able to exercise their rights via the Independent Voting Rights Representative and follow the AGM via live webcast. A video recording of this year’s AGM can be found here.
In his speech to shareholders Michel M. Liès said: “At Zurich, we exist to give people a sense of security during good times and to support them when things become difficult. We, as an insurance company, have been doing this for 150 years. The last year – indeed the last two years of the pandemic – have required swift and decisive action. Let me say here, not without pride: we have passed the test.”
Michel M. Liès, Chairman of the Board of Directors
Group Chief Executive Officer Mario Greco said: “We achieved a strong result in 2021 thanks to all our employees and despite facing increasing risks such as those from global warming. Our loyal customers understand that we always keep them front and center, even in the most unusual times. I’m convinced Zurich is ready to meet the challenges of the future, thanks to our transformation over recent years.”
Mario Greco, Group Chief Executive Officer
Shareholders also approved the dividend of CHF 22 per share, which will be paid from April 12, 2022. In a non-binding advisory vote, 73.87% of the represented shareholders approved the remuneration report 2021. All other Board proposals were also approved. The detailed voting results will be published on www.zurich.com on April 6, 2022.
The Board of Directors and the Remuneration Committee consist of the following members:
Board of Directors
- Michel M. Liès, Chairman
- Joan Amble
- Catherine Bessant
- Dame Alison Carnwath
- Christoph Franz
- Michael Halbherr
- Sabine Keller-Busse
- Monica Mächler
- Kishore Mahbubani
- Peter Maurer (joining the Board on October 1, 2022)
- Jasmin Staiblin
- Barry Stowe
Remuneration Committee
- Christoph Franz, Chairman
- Catherine Bessant
- Sabine Keller-Busse
- Michel M. Liès
- Kishore Mahbubani
- Jasmin Staiblin
The CVs of all members of the Board as well as the Board committees’ composition can be found here.
More information about Zurich’s Corporate Governance structure can be found here.
Downloads
Contacts
- Media Relations
- Investor Relations
Zurich Insurance Group (Zurich) is a leading multi-line insurer serving more than 55 million customers – both people and businesses – in more than 210 countries and territories. Founded 150 years ago, Zurich is transforming insurance. In addition to providing insurance protection, Zurich is increasingly offering prevention services such as those that promote wellbeing and enhance climate resilience.
Reflecting its purpose to ‘create a brighter future together’, Zurich aspires to be one of the most responsible and impactful businesses in the world. It is targeting net-zero emissions by 2050 and is one of the world’s most sustainable insurers, as shown by the S&P Global Corporate Sustainability Assessment. In 2020, Zurich launched the Zurich Forest project to support reforestation and biodiversity restoration in Brazil.
The Group has about 56,000 employees and is headquartered in Zurich, Switzerland. Zurich Insurance Group Ltd (ZURN), is listed on the SIX Swiss Exchange and has a level I American Depositary Receipt (ZURVY) program, which is traded over-the-counter on OTCQX. Further information is available at www.zurich.com.